Main menu


You are here

Treatments

New booster:

U.S. starts enrollments in trial testing smaller dosage of monkeypox vaccine

U.S. starts enrollments in trial testing smaller dosage of monkeypox vaccine

Reuters--

...

U.S. health regulators last month authorized injecting the shot intradermally in adults, meaning between layers of the skin rather than below the skin, in an effort to stretch out low vaccine supplies. read more

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Nasel spray vaccines might stop the coronavirus in its tracks, although there’s little evidence from human trials so far.

...

These mucosal vaccines target thin mucous membranes that line the nose, mouth and lungs. By prompting immune responses where SARS-CoV-2 first enters the body, mucosal vaccines could, in theory, prevent even mild cases of illness and block transmission to other people — something COVID-19 shots have been unable to do. Vaccines that produce sterilizing immunity would be game changing for the pandemic. ...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Treatments
howdy folks
Page loaded in 0.620 seconds.